Venlafaxine (Effexor): Concerns about increased risk of fatal outcomes in overdose

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 1, 2007, Pages 39-40

  Deshauer, Dorian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOXEPIN; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; CANADA; DATA BASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG FATALITY; DRUG INDUSTRY; DRUG OVERDOSE; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HEART DISEASE; HIGH RISK POPULATION; HUMAN; MAJOR DEPRESSION; OUTCOME ASSESSMENT; PRESCRIPTION; RISK ASSESSMENT; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL PHOBIA; SUICIDE; SUSTAINED DRUG RELEASE; SWEATING; UNITED KINGDOM; UNITED STATES; XEROSTOMIA;

EID: 33846455086     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.061533     Document Type: Article

References (5)

1. Buckley NA, McManus PR. Fatal toxicity of serotonergic and other antidepressant drugs: analysis of UK mortality data. BMJ 2002;325:1332-3.
2. Morgan O, Griffiths C, Baker A, et al. Fatal toxicity of antidepressants in England and Wales, 1993-2002. Health Stat Q 2004;(23):18-24.
3. Cheeta S, Schifano F, Oyefeso A, et al. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. Br J Psychiatry 2004;184:41-7.
4. Koski A, Vuori E, Ojanpera I. Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 2005;119:344-8.
5. Mines D, Hill D, Yu H, et al. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiol Drug Saf 2005;14:367-72.